Houston, TX – 10/01/2020. DermaClip® today announced the promotion of Dr. Mark L. Waltzman, MD, FAAP, to the role of Chairman of the Medical Advisory Board. An Assistant Professor of Pediatrics at Harvard Medical School and the Chief of Pediatrics at South Shore Hospital, Dr. Waltzman's experience in emergency medicine coupled with his expertise related to care for pediatric patients is significant to the DermaClip efforts for further expansion into emergency departments and urgent care centers across the United States.
"Dr. Waltzman's advice and guidance has been of tremendous benefit to the Company thus far and we are so pleased that he has agreed to take on this larger role to help further our efforts," said Charles M. Darling IV, CEO of DermaClip.
DermaClip® aims to optimize incision, laceration and wound repair through non-invasive, cost-effective and efficiency-producing skin closure devices. Named an R&D 100 winner as one of the 100 top innovations in 2020, the DermaClip device is a non-invasive skin closure device that is an alternative to sutures, surgical staples and glues. The device aims to improve the patient experience while reducing the time and cost burden of closure by transforming a highly variable skill into a reproducible process. The device has been used in more than 30,000 cases, everywhere from in the field to the Emergency Department to the surgical suite. The DermaClip team believes that high quality skin closure should be available to everyone, regardless of access to high-end services. The team aims to eliminate the trade-offs in skin closure made between time of closure and quality of patient care. DermaClip is headquartered in Houston, TX. For more information, visit the DermaClip website. You can also find more about the DermaClip devices on Twitter, Facebook, LinkedIn, and Instagram.